Clin Mol Hepatol.
2017 Dec;23(4):308-310. 10.3350/cmh.2017.0109.
Use of sofosbuvir in chronic kidney disease: Is it necessary?
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. AHNSH@yuhs.ac
- 2Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
- 3Yonsei Liver Center, Severance Hospital, Seoul, Korea.
- 4Brain Korea 21 Project for Medical Science, Seoul, Korea.
- KMID: 2406037
- DOI: http://doi.org/10.3350/cmh.2017.0109
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
- Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
- Outcomes of Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir in Mongolian Population: Successes and Challenges Facing Scale-up of Care
- The gut-kidney connection in advanced chronic kidney disease
- Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
